SIGNATURE CLIENT SERVICE
Live / Registered — Registered and renewed (as of 21 May 2020)
What this means for you
Registered since 15 Sept 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Sept 2019).
Record
- Serial number
- 78626624
- Registration number
- 3684477
- Mark type
- Stylized text
- Filed
- 10 May 2005
- Published for opposition
- 04 Apr 2006
- Registered
- 15 Sept 2009
- Next maintenance due
- 15 Sept 2019
- Attorney of record
- William M. Bryner
Goods and services
- Class 035 — Advertising and business services: Economic forecasting and analysis for the health industry; business management and consulting services for the health industry in the field of marketing, research, and development; market research, namely, collecting market trends data from providers and patients, data on health economic issues, and competitive intelligence data on the marketplace for pharmaceutical products and medical devices; administering customer service programs, namely, operating patient assistance programs for pharmaceutical products and medical devices, and providing access to advocacy groups and counseling for patients to promote patient satisfaction; computer services, namely, providing a database for tracking, monitoring, and generating reports on information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices
- Class 042 — Scientific and technological services: Testing and development of pharmaceuticals, biotechnology products, and medical devices; organizing and managing clinical trials for pharmaceuticals, biotechnology products, and medical devices for others; clinical research services, namely, collection, calibration, analysis, and reporting of data in connection with clinical trials of pharmaceutical, biotechnology products, and medical devices; consulting and support services in the field of clinical trials of pharmaceuticals, namely, forecasting drug supply requirements for clinical trials, monitoring drug supplies in clinical trials, and analyzing and reporting data related to the foregoing
Owner
- LABCORP DRUG DEVELOPMENT INC., PRINCETON, NJ, US
- COVANCE INC., Princeton, NJ, US
- COVANCE INC., Princeton, NJ, US
- COVANCE INC., Princeton, NJ, US
Prosecution history
- 07 Sept 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 May 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 May 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 May 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 May 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Mar 2020 — TEAS SECTION 8 & 9 RECEIVED
- 20 Sept 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Sept 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Sept 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Oct 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Oct 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Oct 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Sept 2015 — TEAS SECTION 8 & 15 RECEIVED
- 15 Sept 2009 — REGISTERED-PRINCIPAL REGISTER
- 13 Aug 2009 — LAW OFFICE REGISTRATION REVIEW COMPLETED